Founded in 2013, Aerobiotix, a rapidly growing global medical company has raised a $25 million of growth equity financing. The round was led by Vivo Capital with participation by Asahi Kasei Ventures. The new funding will be used to accelerate sales, marketing, and new product development. Aerobiotix products provide mechanical and ultraviolet filtration to remove…
Aerobiotix Raises $25M Growth Equity Financing Led by Global Healthcare Investment Firm Vivo Capital
More from ProductMore posts in Product »
- US Patent Issued 2025 – US 12329865 B2 “Self-sanitizing system for vehicle cabins”
- US Patent Issued 2025 – US 12329867 B2 “Methods and systems for treatment of vehicle surfaces and air”
- US Patent Application – US 20250197926 A1 “SYSTEM FOR DISINFECTING TEXTILES IN A HOUSEHOLD APPLIANCE
- Self-Contained Dianostic Tool “H3 Health Cube”Now Active In Market
- US Patent Application – US 20250186638 A1 “Method and Technique for the Focusing of UVC Light Energy to a Focused Energy Beam”